Xpert Xpress SARS-CoV-2 Test

News Releases

Month Year

Month Year

Sep 6, 2016

Cepheid Agrees To Be Acquired By Danaher Corporation For $53 Per Share In Cash
Aug 4, 2016

Cepheid to Webcast Upcoming Financial Presentations
Jul 28, 2016

Cepheid Reports Second Quarter 2016 Results
Jul 12, 2016

Cepheid Announces Results Of Validation Study For Use Of Xpert HPV In Primary Cervical Cancer Screening

Xpert HPV Fulfills International Requirements for Use as Primary Screening Test
Jul 7, 2016

Cepheid Schedules 2016 Second Quarter Results Announcement And Webcast

Show per page

Back to Top